Senior R&D Scientist, Genome and Epigenome Editing, MilliporeSigma
Biography
Andrew has spent more than a decade using genetic manipulation and analysis to dissect molecular mechanisms involved in cell fate specification and behavior in cell culture and in animal models of development and disease. He earned his Ph.D. in Cell Biology from Duke University and completed a postdoctoral fellowship in Pediatrics at the University of Colorado School of Medicine, developing expertise in high-throughput screening, developmental neuroscience, and gene editing. Andrew joined MilliporeSigma in 2016 and has been developing new tools and strategies to modulate gene expression using CRISPR-Cas9.
